Andrew H. Galligan, Chief Financial Officer at NEVRO CORP (NVRO), sold 15,900 shares at $53.90 ($887K) on 2016-03-01, disclosed to the SEC on 2016-03-03.
Open-market sale of $887k NVRO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.30 | 300 | $16K | 1.8% |
| 2 | $53.90 | 1,202 | $65K | 7.3% |
| 3 | $53.90 | 1,202 | $65K | 7.3% |
| 4 | $54.81 | 1,384 | $76K | 8.5% |
| 5 | $54.81 | 1,384 | $76K | 8.5% |
| 6 | $56.07 | 3,100 |
| $174K |
| 19.6% |
| 7 | $56.74 | 3,314 | $188K | 21.2% |
| 8 | $56.74 | 3,314 | $188K | 21.2% |
| 9 | $57.68 | 600 | $35K | 3.9% |
| 10 | $59.06 | 100 | $6K | 0.7% |
| Total | $55.81 avg | 15,900 | $887K | 100% |
| Filing → |
| NVRO | SELL | 2020-01-10 | $4.3M | — | Filing → |
| NVRO | SELL | 2020-01-08 | $334K | — | Filing → |
| NVRO | SELL | 2019-11-26 | $1.3M | — | Filing → |